IMPORTANCE: To better guide strategies intended to reduce high rates of 30-day readmission after hospitalization for heart failure (HF), acute myocardial infarction (MI), or pneumonia, further information is needed about readmission diagnoses, readmission timing, and the relationship of both to patient age, sex, and race. OBJECTIVE: To examine readmission diagnoses and timing among Medicare beneficiaries readmitted within 30 days after hospitalization for HF, acute MI, or pneumonia. DESIGN, SETTING, AND PATIENTS: We analyzed 2007-2009 Medicare fee-for-service claims data to identify patterns of 30-day readmission by patient demographic characteristics and time after hospitalization for HF, acute MI, or pneumonia. Readmission diagnoses were categorized using an aggregated version of the Centers for Medicare & Medicaid Services' Condition Categories. Readmission timing was determined by day after discharge. MAIN OUTCOME MEASURES: We examined the percentage of 30-day readmissions occurring on each day (0-30) after discharge; the most common readmission diagnoses occurring during cumulative periods (days 0-3, 0-7, 0-15, and 0-30) and consecutive periods (days 0-3, 4-7, 8-15, and 16-30) after hospitalization; median time to readmission for common readmission diagnoses; and the relationship between patient demographic characteristics and readmission diagnoses and timing. RESULTS: From 2007 through 2009, we identified 329,308 30-day readmissions after 1,330,157 HF hospitalizations (24.8% readmitted), 108,992 30-day readmissions after 548,834 acute MI hospitalizations (19.9% readmitted), and 214,239 30-day readmissions after 1,168,624 pneumonia hospitalizations (18.3% readmitted). The proportion of patients readmitted for the same condition was 35.2% after the index HF hospitalization, 10.0% after the index acute MI hospitalization, and 22.4% after the index pneumonia hospitalization. Of all readmissions within 30 days of hospitalization, the majority occurred within 15 days of hospitalization: 61.0%, HF cohort; 67.6%, acute MI cohort; and 62.6%, pneumonia cohort. The diverse spectrum of readmission diagnoses was largely similar in both cumulative and consecutive periods after discharge. Median time to 30-day readmission was 12 days for patients initially hospitalized for HF, 10 days for patients initially hospitalized for acute MI, and 12 days for patients initially hospitalized for pneumonia and was comparable across common readmission diagnoses. Neither readmission diagnoses nor timing substantively varied by age, sex, or race. CONCLUSION AND RELEVANCE: Among Medicare fee-for-service beneficiaries hospitalized for HF, acute MI, or pneumonia, 30-day readmissions were frequent throughout the month after hospitalization and resulted from a similar spectrum of readmission diagnoses regardless of age, sex, race, or time after discharge.
IMPORTANCE: To better guide strategies intended to reduce high rates of 30-day readmission after hospitalization for heart failure (HF), acute myocardial infarction (MI), or pneumonia, further information is needed about readmission diagnoses, readmission timing, and the relationship of both to patient age, sex, and race. OBJECTIVE: To examine readmission diagnoses and timing among Medicare beneficiaries readmitted within 30 days after hospitalization for HF, acute MI, or pneumonia. DESIGN, SETTING, AND PATIENTS: We analyzed 2007-2009 Medicare fee-for-service claims data to identify patterns of 30-day readmission by patient demographic characteristics and time after hospitalization for HF, acute MI, or pneumonia. Readmission diagnoses were categorized using an aggregated version of the Centers for Medicare & Medicaid Services' Condition Categories. Readmission timing was determined by day after discharge. MAIN OUTCOME MEASURES: We examined the percentage of 30-day readmissions occurring on each day (0-30) after discharge; the most common readmission diagnoses occurring during cumulative periods (days 0-3, 0-7, 0-15, and 0-30) and consecutive periods (days 0-3, 4-7, 8-15, and 16-30) after hospitalization; median time to readmission for common readmission diagnoses; and the relationship between patient demographic characteristics and readmission diagnoses and timing. RESULTS: From 2007 through 2009, we identified 329,308 30-day readmissions after 1,330,157 HF hospitalizations (24.8% readmitted), 108,992 30-day readmissions after 548,834 acute MI hospitalizations (19.9% readmitted), and 214,239 30-day readmissions after 1,168,624 pneumonia hospitalizations (18.3% readmitted). The proportion of patients readmitted for the same condition was 35.2% after the index HF hospitalization, 10.0% after the index acute MI hospitalization, and 22.4% after the index pneumonia hospitalization. Of all readmissions within 30 days of hospitalization, the majority occurred within 15 days of hospitalization: 61.0%, HF cohort; 67.6%, acute MI cohort; and 62.6%, pneumonia cohort. The diverse spectrum of readmission diagnoses was largely similar in both cumulative and consecutive periods after discharge. Median time to 30-day readmission was 12 days for patients initially hospitalized for HF, 10 days for patients initially hospitalized for acute MI, and 12 days for patients initially hospitalized for pneumonia and was comparable across common readmission diagnoses. Neither readmission diagnoses nor timing substantively varied by age, sex, or race. CONCLUSION AND RELEVANCE: Among Medicare fee-for-service beneficiaries hospitalized for HF, acute MI, or pneumonia, 30-day readmissions were frequent throughout the month after hospitalization and resulted from a similar spectrum of readmission diagnoses regardless of age, sex, race, or time after discharge.
Authors: Patricia S Keenan; Sharon-Lise T Normand; Zhenqiu Lin; Elizabeth E Drye; Kanchana R Bhat; Joseph S Ross; Jeremiah D Schuur; Brett D Stauffer; Susannah M Bernheim; Andrew J Epstein; Yongfei Wang; Jeph Herrin; Jersey Chen; Jessica J Federer; Jennifer A Mattera; Yun Wang; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2008-09
Authors: Adrian F Hernandez; Melissa A Greiner; Gregg C Fonarow; Bradley G Hammill; Paul A Heidenreich; Clyde W Yancy; Eric D Peterson; Lesley H Curtis Journal: JAMA Date: 2010-05-05 Impact factor: 56.272
Authors: Christopher M O'Connor; Alan B Miller; John E A Blair; Marvin A Konstam; Patricia Wedge; Maria C Bahit; Peter Carson; Markus Haass; Paul J Hauptman; Marco Metra; Ron M Oren; Richard Patten; Ileana Piña; Sherryn Roth; Jonathan D Sackner-Bernstein; Brian Traver; Thomas Cook; Mihai Gheorghiade Journal: Am Heart J Date: 2010-05 Impact factor: 4.749
Authors: Susannah M Bernheim; Jacqueline N Grady; Zhenqiu Lin; Yun Wang; Yongfei Wang; Shantal V Savage; Kanchana R Bhat; Joseph S Ross; Mayur M Desai; Angela R Merrill; Lein F Han; Michael T Rapp; Elizabeth E Drye; Sharon-Lise T Normand; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2010-08-24
Authors: Peter K Lindenauer; Susannah M Bernheim; Jacqueline N Grady; Zhenqiu Lin; Yun Wang; Yongfei Wang; Angela R Merrill; Lein F Han; Michael T Rapp; Elizabeth E Drye; Sharon-Lise T Normand; Harlan M Krumholz Journal: J Hosp Med Date: 2010 Jul-Aug Impact factor: 2.960
Authors: Joseph S Ross; Jersey Chen; Zhenqiu Lin; Héctor Bueno; Jeptha P Curtis; Patricia S Keenan; Sharon-Lise T Normand; Geoffrey Schreiner; John A Spertus; Maria T Vidán; Yongfei Wang; Yun Wang; Harlan M Krumholz Journal: Circ Heart Fail Date: 2009-11-10 Impact factor: 8.790
Authors: Brian W Jack; Veerappa K Chetty; David Anthony; Jeffrey L Greenwald; Gail M Sanchez; Anna E Johnson; Shaula R Forsythe; Julie K O'Donnell; Michael K Paasche-Orlow; Christopher Manasseh; Stephen Martin; Larry Culpepper Journal: Ann Intern Med Date: 2009-02-03 Impact factor: 25.391
Authors: Julie Sochalski; Tiny Jaarsma; Harlan M Krumholz; Ann Laramee; John J V McMurray; Mary D Naylor; Michael W Rich; Barbara Riegel; Simon Stewart Journal: Health Aff (Millwood) Date: 2009 Jan-Feb Impact factor: 6.301
Authors: Alexandra Ortego; David F Gaieski; Barry D Fuchs; Tiffanie Jones; Scott D Halpern; Dylan S Small; S Cham Sante; Byron Drumheller; Jason D Christie; Mark E Mikkelsen Journal: Crit Care Med Date: 2015-04 Impact factor: 7.598
Authors: Bobak J Mortazavi; Nicholas S Downing; Emily M Bucholz; Kumar Dharmarajan; Ajay Manhapra; Shu-Xia Li; Sahand N Negahban; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2016-11-08
Authors: Juan F Delgado; Andreu Ferrero Gregori; Laura Morán Fernández; Ramón Bascompte Claret; Andrés Grau Sepúlveda; Francisco Fernández-Avilés; José R González-Juanatey; Rafael Vázquez García; Miguel Rivera Otero; Javier Segovia Cubero; Domingo Pascual Figal; Maria G Crespo-Leiro; Jesús Alvarez-García; Juan Cinca; Fernando Arribas Ynsaurriaga Journal: Curr Heart Fail Rep Date: 2019-12
Authors: Tudor Borza; Mary K Oerline; Ted A Skolarus; Edward C Norton; Justin B Dimick; Bruce L Jacobs; Lindsey A Herrel; Chad Ellimoottil; John M Hollingsworth; Andrew M Ryan; David C Miller; Vahakn B Shahinian; Brent K Hollenbeck Journal: Ann Surg Date: 2019-05 Impact factor: 12.969
Authors: Brian M Salata; Madeline R Sterling; Ashley N Beecy; Ajayram V Ullal; Erica C Jones; Evelyn M Horn; Parag Goyal Journal: Am J Cardiol Date: 2018-02-07 Impact factor: 2.778